HighTower Advisors’s Ocugen OCGN Stock Holding History

HighTower Advisors’s Portfolio OCGN Stock Details OCGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,400	Closed	-$1K	–	3418
2021 Q3	$1K	Buy	+1,400	New	+$10.3K	﹤0.01%	3140

Other funds holding OCGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

HighTower Advisors's OCGN Position: Q1 2024 in Review

HighTower Advisors sold out of Ocugen (OCGN) in Q1 2024, closing a stake of 10,311 shares — an estimated $6K sold.

HighTower Advisors first reported a position in OCGN in Q3 2021 and held it in 5 quarters. The position peaked at $163K in Q3 2021. 81 funds tracked by Wall St. Rank hold OCGN as of Q1 2024.

HighTower Advisors reported no remaining Ocugen position as of Q1 2024 after selling out during the quarter.
HighTower Advisors sold 10,311 Ocugen shares in Q1 2024, an estimated $6K.
HighTower Advisors first reported a position in Ocugen in Q3 2021 and held it in 5 quarters.
HighTower Advisors's Ocugen position peaked at $163K in Q3 2021.
81 funds tracked by Wall St. Rank held Ocugen as of Q1 2024.

Based on HighTower Advisors's 13F filing for Q1 2024, filed 6 May 2024.